Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention (original) (raw)

Journal Article

,

Affiliations of authors: Institut d'Investigació Biomèdica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d'Oncologia. L'Hospitalet de Llobregat, Barcelona, Spain (XC, MD, SdS, NM, FXB); Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, San José, Costa Rica (RH); International Agency for Research on Cancer, Lyons, France (SF); National Laboratory for Sexually Transmitted Diseases, Health Canada, Winnipeg, Manitoba, Canada (RWP); University of Washington, Seattle, WA (RA); University of North Carolina, Chapel Hill, NC (JSS); Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands (PJFS, CJLMM)

Correspondence to: Xavier Castellsagué, MD, MPH, PhD, Servei d'Epidemiologia i Registre del Càncer, Institut Català d'Oncologia, Gran via s/n, km 2.7, E-08907 L'Hospitalet de Llobregat, Barcelona, Spain (e-mail: xcastellsague@ico.scs.es ).

Search for other works by this author on:

,

Affiliations of authors: Institut d'Investigació Biomèdica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d'Oncologia. L'Hospitalet de Llobregat, Barcelona, Spain (XC, MD, SdS, NM, FXB); Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, San José, Costa Rica (RH); International Agency for Research on Cancer, Lyons, France (SF); National Laboratory for Sexually Transmitted Diseases, Health Canada, Winnipeg, Manitoba, Canada (RWP); University of Washington, Seattle, WA (RA); University of North Carolina, Chapel Hill, NC (JSS); Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands (PJFS, CJLMM)

Search for other works by this author on:

,

Affiliations of authors: Institut d'Investigació Biomèdica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d'Oncologia. L'Hospitalet de Llobregat, Barcelona, Spain (XC, MD, SdS, NM, FXB); Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, San José, Costa Rica (RH); International Agency for Research on Cancer, Lyons, France (SF); National Laboratory for Sexually Transmitted Diseases, Health Canada, Winnipeg, Manitoba, Canada (RWP); University of Washington, Seattle, WA (RA); University of North Carolina, Chapel Hill, NC (JSS); Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands (PJFS, CJLMM)

Search for other works by this author on:

,

Affiliations of authors: Institut d'Investigació Biomèdica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d'Oncologia. L'Hospitalet de Llobregat, Barcelona, Spain (XC, MD, SdS, NM, FXB); Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, San José, Costa Rica (RH); International Agency for Research on Cancer, Lyons, France (SF); National Laboratory for Sexually Transmitted Diseases, Health Canada, Winnipeg, Manitoba, Canada (RWP); University of Washington, Seattle, WA (RA); University of North Carolina, Chapel Hill, NC (JSS); Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands (PJFS, CJLMM)

Search for other works by this author on:

,

Affiliations of authors: Institut d'Investigació Biomèdica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d'Oncologia. L'Hospitalet de Llobregat, Barcelona, Spain (XC, MD, SdS, NM, FXB); Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, San José, Costa Rica (RH); International Agency for Research on Cancer, Lyons, France (SF); National Laboratory for Sexually Transmitted Diseases, Health Canada, Winnipeg, Manitoba, Canada (RWP); University of Washington, Seattle, WA (RA); University of North Carolina, Chapel Hill, NC (JSS); Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands (PJFS, CJLMM)

Search for other works by this author on:

,

Affiliations of authors: Institut d'Investigació Biomèdica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d'Oncologia. L'Hospitalet de Llobregat, Barcelona, Spain (XC, MD, SdS, NM, FXB); Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, San José, Costa Rica (RH); International Agency for Research on Cancer, Lyons, France (SF); National Laboratory for Sexually Transmitted Diseases, Health Canada, Winnipeg, Manitoba, Canada (RWP); University of Washington, Seattle, WA (RA); University of North Carolina, Chapel Hill, NC (JSS); Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands (PJFS, CJLMM)

Search for other works by this author on:

,

Affiliations of authors: Institut d'Investigació Biomèdica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d'Oncologia. L'Hospitalet de Llobregat, Barcelona, Spain (XC, MD, SdS, NM, FXB); Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, San José, Costa Rica (RH); International Agency for Research on Cancer, Lyons, France (SF); National Laboratory for Sexually Transmitted Diseases, Health Canada, Winnipeg, Manitoba, Canada (RWP); University of Washington, Seattle, WA (RA); University of North Carolina, Chapel Hill, NC (JSS); Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands (PJFS, CJLMM)

Search for other works by this author on:

,

Affiliations of authors: Institut d'Investigació Biomèdica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d'Oncologia. L'Hospitalet de Llobregat, Barcelona, Spain (XC, MD, SdS, NM, FXB); Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, San José, Costa Rica (RH); International Agency for Research on Cancer, Lyons, France (SF); National Laboratory for Sexually Transmitted Diseases, Health Canada, Winnipeg, Manitoba, Canada (RWP); University of Washington, Seattle, WA (RA); University of North Carolina, Chapel Hill, NC (JSS); Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands (PJFS, CJLMM)

Search for other works by this author on:

,

Affiliations of authors: Institut d'Investigació Biomèdica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d'Oncologia. L'Hospitalet de Llobregat, Barcelona, Spain (XC, MD, SdS, NM, FXB); Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, San José, Costa Rica (RH); International Agency for Research on Cancer, Lyons, France (SF); National Laboratory for Sexually Transmitted Diseases, Health Canada, Winnipeg, Manitoba, Canada (RWP); University of Washington, Seattle, WA (RA); University of North Carolina, Chapel Hill, NC (JSS); Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands (PJFS, CJLMM)

Search for other works by this author on:

,

Affiliations of authors: Institut d'Investigació Biomèdica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d'Oncologia. L'Hospitalet de Llobregat, Barcelona, Spain (XC, MD, SdS, NM, FXB); Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, San José, Costa Rica (RH); International Agency for Research on Cancer, Lyons, France (SF); National Laboratory for Sexually Transmitted Diseases, Health Canada, Winnipeg, Manitoba, Canada (RWP); University of Washington, Seattle, WA (RA); University of North Carolina, Chapel Hill, NC (JSS); Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands (PJFS, CJLMM)

Search for other works by this author on:

... Show more

Revision received:

20 December 2005

Accepted:

11 January 2006

• • Article contents
  • Figures & tables
  • Video
  • Audio
  • Supplementary Data
• Cite

Cite

Xavier Castellsagué, Mireia Díaz, Silvia de Sanjosé, Nubia Muñoz, Rolando Herrero, Silvia Franceschi, Rosanna W. Peeling, Rhoda Ashley, Jennifer S. Smith, Peter J. F. Snijders, Chris J. L. M. Meijer, F. Xavier Bosch, For the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group, Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention, JNCI: Journal of the National Cancer Institute, Volume 98, Issue 5, 1 March 2006, Pages 303–315, https://doi.org/10.1093/jnci/djj067
Close

Navbar Search Filter Mobile Enter search term Search

Abstract

Background: Most cancers of the uterine cervix are squamous cell carcinomas. Although the incidence of such carcinomas of the uterine cervix has declined over time, that of cervical adenocarcinoma has risen in recent years. The extent to which human papillomavirus (HPV) infection and cofactors may explain this differential trend is unclear. Methods: We pooled data from eight case–control studies of cervical cancer that were conducted on three continents. A total of 167 case patients with invasive cervical adenocarcinoma (112 with adenocarcinoma and 55 with adenosquamous carcinoma) and 1881 hospital-based control subjects were included. HPV DNA was analyzed in cervical specimens with the GP5+/6+ general primer system followed by type-specific hybridization for 33 HPV genotypes. Blood samples were analyzed for chlamydial and herpes simplex virus 2 (HSV-2) serology. Multivariable unconditional logistic regression modeling was used to calculate odds ratios (ORs) with 95% confidence intervals (CIs). All tests of statistical significance were two-sided. Results: The adjusted overall odds ratio for cervical adenocarcinoma in HPV-positive women compared with HPV-negative women was 81.3 (95% CI = 42.0 to 157.1). HPV 16 and HPV 18 were the two most commonly detected HPV types in case patients and control subjects. These two types were present in 82% of the patients. Cofactors that showed clear statistically significant positive associations with cervical adenocarcinoma overall and among HPV-positive women included never schooling, poor hygiene, sexual behavior–related variables, long-term use of hormonal contraception, high parity, and HSV-2 seropositivity. Parity had a weaker association with adenocarcinoma and only among HPV-positive women. Use of an intrauterine device (IUD) had a statistically significant inverse association with risk of adenocarcinoma (for ever use of an IUD compared with never use, OR = .41 [95% CI = 0.18 to 0.93]). Smoking and chlamydial seropositivity were not associated with disease. Conclusions: HPV appears to be the key risk factor for cervical adenocarcinoma. HPV testing in primary screening using current mixtures of HPV types and HPV vaccination against main HPV types should reduce the incidence of this cancer worldwide.

© The Author 2006. Published by Oxford University Press.

Topic:

• adenocarcinoma
• human papillomavirus
• dna
• adenocarcinoma of cervix

You do not currently have access to this article.

Personal account

• Sign in with email/username & password
• Get email alerts
• Save searches
• Purchase content
• Activate your purchase/trial code
• Add your ORCID iD

Get help with access

Institutional access

Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:

IP based access

Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.

Sign in through your institution

Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.

1. Click Sign in through your institution.
2. Select your institution from the list provided, which will take you to your institution's website to sign in.
3. When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
4. Following successful sign in, you will be returned to Oxford Academic.

If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.

Sign in with a library card

Enter your library card number to sign in. If you cannot sign in, please contact your librarian.

Society Members

Society member access to a journal is achieved in one of the following ways:

Sign in through society site

Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:

1. Click Sign in through society site.
2. When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
3. Following successful sign in, you will be returned to Oxford Academic.

If you do not have a society account or have forgotten your username or password, please contact your society.

Sign in using a personal account

Some societies use Oxford Academic personal accounts to provide access to their members. See below.

Personal account

A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.

Some societies use Oxford Academic personal accounts to provide access to their members.

Viewing your signed in accounts

Click the account icon in the top right to:

• View your signed in personal account and access account management features.
• View the institutional accounts that are providing access.

Signed in but can't access content

Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.

Institutional account management

For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.

Purchase

Short-term Access

To purchase short-term access, please sign in to your personal account above.

Don't already have a personal account? Register

Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention - 24 Hours access

EUR €38.00

GBP £33.00

USD $41.00

Rental

This article is also available for rental through DeepDyve.

Citations

Views

Altmetric

Metrics

Total Views 5,276

3,821 Pageviews

1,455 PDF Downloads

Since 11/1/2016

Citations

464 Web of Science

×

Email alerts

Citing articles via

• Latest

• Most Read

• Most Cited

More from Oxford Academic